Financial Times |
Novartis sells stake in consumer health venture to GSK for $13bn
Financial Times Novartis has sold its stake in its consumer health joint venture with GlaxoSmithKline to its British rival for $13bn in an early move by Vas Narasimhan, the Swiss pharmaceuticals group's new boss, to focus on its core business. The sale of the 36.5 per ... Glaxo to Buy Novartis Consumer Venture Stake for $13 Billion GSK agrees £9bn deal for Novartis consumer healthcare joint venture stake GlaxoSmithKline to Buy Out Novartis's Stake in Health-Care Venture for $13 Billion |
from Top Stories - Google News https://ift.tt/2I36AjJ
Post a Comment